FDA's New Digital Health Unit and Guidance for MHealth and Telemedicine Companies
June 26, 2017
In connection with its efforts to support technological innovation and advancement of digital health, the U.S. Food and Drug Administration (FDA) has announced two new resources: 1) the creation of a new centralized Digital Health Unit within its Center for Devices and Radiological Health (CDRH) and 2) the issuance of draft guidance on Software as a Medical Device (SaMD): Clinical Evaluation released last fall.
SaMD is an area of digital health where FDA guidance has been rapidly evolving.
To continue reading this article written by Nathaniel Lacktman, Jason Drori and Taylor Whitten, click here.
SaMD is an area of digital health where FDA guidance has been rapidly evolving.
To continue reading this article written by Nathaniel Lacktman, Jason Drori and Taylor Whitten, click here.
Author(s)
Related Insights
July 25, 2025
Foley Viewpoints
Thorny Laws That ICHRA Vendors Should Consider, Part Three: FinTech Edition
We continue our series on the legal and regulatory challenges facing individual coverage health reimbursement arrangements (ICHRAs); this…
July 24, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
July 23, 2025
Foley Viewpoints
The One Big Beautiful Bill and Workplace Immigration Enforcement
The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to…